Name of bioresource/bank
Biobank – CHU Angers
Name of Principal Investigator
Address of institution where award is held
|Institution||Centre hospitalier Universitaire – IBS|
|Street Address||4 rue Larrey|
Contact email (e.g. manager or coordinator)
The Universitary Hospital Center is a public health establishement; its activities are funded by the French Health Minister, the French Research minister and the Region Pays de la Loire
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Motor neurone diseases Huntington’s disease Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
Q2b What cell lines does your resource hold?
1-50 distinct cell lines
Q2c What tissue (including post-mortem tissue) does your resource hold?
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: blood derivatives Living donors: DNA Living donors: skeletal muscle biopsy Living donors: cerebro-spinal fluid Post-mortem donors: brain Post-mortem donors: spinal cord
Q4 Are tissues/samples/DNA from
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records In a specific study-associated dataset Collected as part of a specific clinical trial(s)
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed) Secondary samples:(derivatives of primary samples) Secondary samples: plasma Secondary samples: DNA Secondary samples: RNA Secondary samples: protein extracts Secondary samples: cell lines derived from primary samples
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In most samples
Q8 What is the status of your tissue/sample/DNA collection?
Collection completed and available for use
Q9 What are the rules and procedures for access?
Apply to PI or co-ordinator at resource Access independent of collaboration with PI Access Committee mechanism Local/ regional access National access International access Access to industry Access for pilot studies permitted Access restricted to peer-reviewed work Resource has own ethics approval so usually no need for separate external ethics approval